Canopy Growth Corporation (CGC) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Earnings Reports
-
Canopy Growth (CGC) Q3 2026: MTL Acquisition to Lift Margins Into High 30s, Reshaping Profit Trajectory
June 15, 2026
-
Canopy Growth (CGC) Q2 2026: Canadian Adult-Use Revenue Surges 30% as Cost Cuts Top $21M
November 07, 2025
-
Canopy Growth (CGC) Q1 2026: Cannabis Revenue Jumps 24% as Cost Cuts Hit 85% of Target
August 08, 2025
-
Canopy Growth (CGC) Q4 2025: $20M Cost Cuts Targeted as Medical Cannabis Outperforms Market
July 06, 2025